RecruitingPhase 2NCT06043440

Down Syndrome Obstructive Sleep Apnea

Randomized Control Trial of Oxygen Therapy in Children and Adolescents With Down Syndrome and Obstructive Sleep Apnea

Sponsor

Brigham and Women's Hospital

Enrollment

230 participants

Start Date

Oct 24, 2023

Study Type

INTERVENTIONAL

Conditions

Obstructive Sleep Apnea Down Syndrome

Summary

The purpose of this study is to assess whether oxygen supplementation during sleep improves working memory and other clinical and patient-reported outcomes among children who have Down Syndrome (DS) with moderate to severe Obstructive Sleep Apnea (OSA).

Eligibility

Min Age: 5 YearsMax Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Oxygen for people with down syndrome and obstructive sleep apnea. The study is currently recruiting participants at 7 locations. People eligible for this study include aged 5 Years to 18 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.